Incidence rate of ovarian cancer cases in Saudi Arabia: an observational descriptive epidemiological analysis of data from Saudi Cancer Registry 2001-2008
- PMID: 25028565
- PMCID: PMC4077694
- DOI: 10.2147/IJWH.S63636
Incidence rate of ovarian cancer cases in Saudi Arabia: an observational descriptive epidemiological analysis of data from Saudi Cancer Registry 2001-2008
Abstract
Purpose: This study provides descriptive epidemiological data, such as the percentage of cases diagnosed, crude incidence rate (CIR), and age-standardized incidence rate (ASIR) of ovarian cancer in Saudi Arabia from 2001-2008.
Patients and methods: A retrospective descriptive epidemiological analysis of all ovarian cancer cases recorded in the Saudi Cancer Registry (SCR) from January 2001-December 2008 was performed. The data were analyzed using descriptive statistics, analysis of variance tests, Poisson regression, and simple linear modeling.
Results: A total of 991 ovarian cancer cases were recorded in the SCR from January 2001-December 2008. The region of Riyadh had the highest overall ASIR at 3.3 cases per 100,000 women, followed by the Jouf and Asir regions at 3.13 and 2.96 cases per 100,000 women. However, Hail and Jazan had the lowest rates at 1.4 and 0.6 cases per 100,000 women, respectively. Compared to Jazan, the incidence rate ratio for the number of ovarian cancer cases was significantly higher (P<0.001) in the Makkah region at 6.4 (95% confidence interval [CI]: 4.13-9.83), followed by Riyadh at 6.3 (95% CI: 4.10-9.82), and the eastern region of Saudi Arabia at 4.52 (95% CI: 2.93-6.98). The predicted annual CIR and ASIR for ovarian cancer in Saudi Arabia could be defined by the equations 0.9 + (0.07× years) and 1.71 + (0.09× years), respectively.
Conclusion: We observed a slight increase in the CIRs and ASIRs for ovarian cancer in Saudi Arabia from 2001-2008. Riyadh, Jouf, and Asir had the highest overall ASIR, while Jazan and Hail had the lowest rates. Makkah, Riyadh, and the eastern region of Saudi Arabia had the highest incidence rate ratio for the number of ovarian cancer cases. Further analytical studies are required to determine the potential risk factors of ovarian cancer among Saudi women.
Keywords: Saudi Cancer Registry; cancer epidemiology; incidence rate; ovarian cancer.
Figures
Similar articles
-
Incidence rate of non-Hodgkin's lymphomas among males in Saudi Arabia: an observational descriptive epidemiological analysis of data from the Saudi Cancer Registry, 2001-2008.Int J Gen Med. 2014 Jun 25;7:311-7. doi: 10.2147/IJGM.S63645. eCollection 2014. Int J Gen Med. 2014. PMID: 25028562 Free PMC article.
-
The incidence rate of female breast cancer in Saudi Arabia: an observational descriptive epidemiological analysis of data from Saudi Cancer Registry 2001-2008.Breast Cancer (Dove Med Press). 2013 Oct 17;5:103-9. doi: 10.2147/BCTT.S50750. eCollection 2013. Breast Cancer (Dove Med Press). 2013. PMID: 24648763 Free PMC article.
-
The incidence rate of thyroid cancer among women in Saudi Arabia: an observational descriptive epidemiological analysis of data from Saudi Cancer Registry 2001-2008.J Immigr Minor Health. 2015 Jun;17(3):638-43. doi: 10.1007/s10903-014-0044-5. J Immigr Minor Health. 2015. PMID: 24859807
-
The Etiology and Epidemiological Features of Acute Pancreatitis in Saudi Arabia: A Systematic Review.Cureus. 2023 Oct 5;15(10):e46511. doi: 10.7759/cureus.46511. eCollection 2023 Oct. Cureus. 2023. PMID: 37927657 Free PMC article. Review.
-
Analysis of the pattern of maxillofacial injuries in Saudi Arabia: A systematic review.Saudi Dent J. 2020 Feb;32(2):61-67. doi: 10.1016/j.sdentj.2019.08.008. Epub 2019 Aug 28. Saudi Dent J. 2020. PMID: 32071533 Free PMC article. Review.
Cited by
-
PD-L1 is highly expressed in ovarian cancer and associated with cancer stem cells populations expressing CD44 and other stem cell markers.BMC Cancer. 2023 Jan 5;23(1):13. doi: 10.1186/s12885-022-10404-x. BMC Cancer. 2023. PMID: 36604635 Free PMC article.
-
Hypertension and Ovarian Cancer: A Case-Control Study in Saudi Arabia.Cureus. 2023 Feb 22;15(2):e35294. doi: 10.7759/cureus.35294. eCollection 2023 Feb. Cureus. 2023. PMID: 36968893 Free PMC article.
-
Assessment of prognostic value of tissue inhibitors of metalloproteinase 3 (TIMP3) protein in ovarian cancer.Libyan J Med. 2021 Dec;16(1):1937866. doi: 10.1080/19932820.2021.1937866. Libyan J Med. 2021. PMID: 34240668 Free PMC article.
-
Histopathological patterns of primary malignant ovarian neoplasms in different age groups in Almadinah Almunawwarah region, KSA.J Taibah Univ Med Sci. 2018 Dec 11;14(1):73-78. doi: 10.1016/j.jtumed.2018.11.005. eCollection 2019 Feb. J Taibah Univ Med Sci. 2018. PMID: 31435393 Free PMC article.
References
-
- Ferlay J, Shine H, Bray F, Forman D, Mathers C, Parkin D. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–2917. - PubMed
-
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. - PubMed
-
- Kusumbe AP, Bapat SA. Ovarian stem cell biology and the emergence of ovarian cancer stem cells. Cancer Stem Cells. 2008:95–110.
-
- Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277–300. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources